Closing Bell: Medexus Pharmaceuticals Inc down on Friday (MDP)

Today during trading, Medexus Pharmaceuticals Inc stock opened at $2.35 and closed at $2.28. Intraday prices ranged from $2.15 to $2.35.

Share prices eased -2.98 percent from the previous day's close of $2.35.

Today across North America, the TSX Composite closed -2.18% at 22227.63, the S&P 500 closed -1.84% at 5346.56, the Dow Jones Industrial Average closed -1.51% at 39737.26 and the Nasdaq Composite closed -2.43% at 16776.16.

Medexus Pharmaceuticals Inc traded under MDP on the Toronto Stock Exchange (TSX).

A total of 45,640 shares was traded during the last trading day, with total trades of 85. On average, Medexus Pharmaceuticals Inc has traded 18,616 shares over the last 5-days and 48,710 year-to-date.

The TSX overall saw 432 price advancers against 4,843 declines and 43 unchanged.

During the prior 52 weeks, MDP.TO has traded as high as $3.53 (August 24,2023) and low as $1.44 (December 04,2023). Moreover, in the last 52 weeks, Medexus Pharmaceuticals Inc's shares have decreased -3.80%, while in 2024, they have reduced -7.69%.

Following today's trading, Medexus Pharmaceuticals Inc has a market capitalization of $55.77 million on a float of 24,459 shares outstanding. Its annual EPS is $-0.01.

Medexus Pharmaceuticals Inc is a TSX Drug Specialty & Generic company headquartered in Toronto, CAN.

Currently, Medexus Pharmaceuticals Inc's consensus rating is "Moderate Buy" based on 4 analysts according to Zacks. From those 4 analysts, 3 have buy ratings and 1 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..